ONESOURCE: Q2 revenue reached Rs 5,162m as PAT rose to Rs 575m

What happened

Q2 consolidated revenue was Rs 5,162.42m and profit after tax (PAT, the profit left after all expenses and taxes) was Rs 574.84m. H1 revenue reached Rs 9,652.65m and PAT Rs 824.81m, while H1 operating cash flow stayed negative.

Confirmed

Global impact / market context

Profit rose, but negative operating cash flow means the core business used more cash than it generated in H1, so reported profit did not convert into cash available. That gap can pressure funding needs and makes cash generation a key test of earnings quality.

Analyst inference

The legacy Sputnik vaccine litigation remains under arbitration, an out-of-court dispute process, so a pending outcome hangs over the company. Investors weighing the profit growth must also weigh weak cash conversion and this unresolved legal claim.

Analyst inference

What to watch

1. H1 operating cash flow remained negative, so watch whether cash generation turns positive in coming quarters. Confirmed
2. Track updates on the Sputnik vaccine arbitration, since a ruling could bring costs or a settlement. Proposed
3. Watch whether revenue growth at Rs 5,162.42m in Q2 continues alongside PAT of Rs 574.84m. Analyst inference

Evidence

• Original source link unavailable